2024
|
Invention
|
Antigen-binding protein and use thereof. The present invention relates to a nanobody or an antige... |
|
Invention
|
Antigen-binding protein and use thereof. A nanobody specifically binding to HER2 or an antigen-bi... |
|
Invention
|
Single-domain antibody specifically binding to cdcp1 and use thereof. A single-domain antibody sp... |
|
Invention
|
Anti-c-met nanobody and use thereof. A nanobody specifically binding to c-MET or an antigen-bindi... |
2023
|
Invention
|
Anti-tumor compound and use thereof. A ligand conjugate, or a tautomer, mesomer, racemate, enanti... |
|
Invention
|
Prodrug compound, preparation method therefor and use thereof. The present invention provides a p... |
|
Invention
|
Toxin molecule suitable for antibody-drug conjugate. A toxin molecule suitable for an antibody-dr... |
|
Invention
|
Antibody-drug conjugate and use thereof. aa formula I. |
|
Invention
|
Multispecific antibody and use thereof. The present invention relates to a multispecific antibody... |
|
Invention
|
Antigen-binding protein and use thereof.
The present application relates to an antigen-binding p... |
|
Invention
|
Antigen-binding protein and use thereof. The present application relates to an antigen-binding pr... |
|
Invention
|
Antigen-binding protein and use thereof. 5050 value of about 1.0 μg/mL or less in a competitive E... |
2022
|
Invention
|
Nitrogen-containing heterocyclic compound, preparation method therefor, intermediate thereof, and... |
|
Invention
|
Antitumor compound and use thereof.
The present application relates to an anti-tumor compound an... |
|
Invention
|
Antitumor compound and its application. An antitumor compound and the use thereof. Specifically, ... |
|
Invention
|
Antitumor compound and use thereof. An antitumor compound and the use thereof. Specifically, the ... |
|
Invention
|
Prodrug compound, preparation method therefor and use thereof.
The present invention provides a ... |
|
Invention
|
Antigen binding protein and use thereof.
An antigen binding protein and the use thereof. The ant... |
|
Invention
|
Toxin molecule suitable for antibody-drug conjugate.
The present invention provides a toxin mole... |
|
Invention
|
Toxin molecule suitable for antibody-drug conjugate. The present invention provides a toxin molec... |
|
Invention
|
Antigen binding protein and use thereof. 5050 of approximately 2 μg/mL or less. |
|
Invention
|
Antigen binding protein and use thereof. An antigen binding protein and the use thereof. The anti... |
2021
|
Invention
|
Anti-b7-h3 antibody and preparation therefor and use thereof.
Provided are an anti-B7-H3 antibod... |
|
Invention
|
Anti-b7-h3 antibody and preparation therefor and use thereof. Provided are an anti-B7-H3 antibody... |
|
Invention
|
Jak kinase inhibitor and preparation and application thereof.
The present invention provides a J... |
|
Invention
|
Jak kinase inhibitor and preparation and application thereof. The present invention provides a JA... |
2020
|
Invention
|
Cyclic molecules as bruton's tyrosine kinase inhibitor.
The present invention relates to a novel... |
|
Invention
|
Cyclic molecules as bruton's tyrosine kinase inhibitor. The present invention describes novel mol... |